Rynki

Twoje finanse

Biznes

Forum

SOPHARMA AD: Notification of didvidend

Spis treści:

1. REPORT

reklama

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
SFA dividend 28062024 EN espi.pdf  (REPORT)

przewiń, aby zobaczyć całą tabelę
POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 70 / 2024
Date of issue: 2024-06-28
Short name of the issuer
SOPHARMA AD
Subject
Notification of didvidend
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Notification of didvidend
Contents of the report:
Notification of didvidend
Annexes
File Description
SFA dividend 28062024 EN espi.pdfSFA_dividend_28062024_EN_espi.pdf Notification of didvidend

przewiń, aby zobaczyć całą tabelę
SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

przewiń, aby zobaczyć całą tabelę
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2024-06-28 Ognian dONEV Executive director
Źródło: Komunikaty spółek (ESPI)
powiązane
polecane
najnowsze
popularne
najnowsze
bankier na skróty